Stryve Foods (SNAX) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Net sales grew 36.4% year-over-year to $5.7 million in Q3 2024, driven by increased retail velocity, expanded distribution, and improved product demand.
Gross profit more than doubled year-over-year, with gross margin improving to 21.7% from 13.3%, reflecting transformation initiatives and improved pricing.
Operating loss narrowed to $2.3 million from $3.7 million in Q3 2023, and net loss improved to $3.1 million, or $0.95 per share.
Demand exceeded supply due to working capital constraints, which are being addressed through a recent $2.9 million equity raise.
The company is in the final phase of its transformation plan, focusing on quality growth, brand reinvigoration, and expanded distribution, including new product launches like High Steaks pet treats.
Financial highlights
Q3 2024 net sales: $5.7 million (+36.4% YoY); nine months: $16.5 million (+11.2% YoY).
Q3 2024 gross profit: $1.2 million (21.7% margin); nine months: $3.9 million (23.9% margin).
Q3 2024 operating expenses: $3.5 million, down 15.9% YoY; nine months: $11.5 million, down 17% YoY.
Adjusted EBITDA loss improved by 31.5% to $1.7 million in Q3 2024; nine months: $5.5 million, a 34% improvement YoY.
Q3 2024 net loss: $3.1 million ($0.95/share); nine months: $10.0 million ($3.22/share).
Outlook and guidance
Anticipates significant year-over-year growth in Q4, potentially approaching or exceeding 100%, with further margin expansion and net loss reduction expected as transformation initiatives mature.
Not providing formal guidance for the remainder of 2024 due to timing of capital raise, but expects Q4 shipments to benefit from improved working capital.
Management expects continued sales growth if current retail velocity trends persist and working capital constraints are addressed, with meaningful contribution to profitability from expanded distribution in Q1 2025.
Latest events from Stryve Foods
- Gross margin hit 27.4% and FY 2024 sales are guided up, but liquidity risks remain.SNAX
Q2 20241 Feb 2026 - Shareholders to vote on key warrant-related share issuances to enable future capital access.SNAX
Proxy Filing1 Dec 2025 - Adjourned vote seeks quorum for key proposals enabling new financing, with strong support so far.SNAX
Proxy Filing1 Dec 2025 - Stockholders will vote on key share issuances and meeting adjournment to support capital needs.SNAX
Proxy Filing1 Dec 2025 - Offering up to $3M in shares and warrants amid losses and Nasdaq delisting risk.SNAX
Registration Filing29 Nov 2025 - Unprofitable healthy snack maker seeks $15.7M–$18.0M via equity/warrants to address liquidity and listing risks.SNAX
Registration Filing29 Nov 2025 - IPO seeks $15.7M–$18M to fund operations and debt amid losses and Nasdaq delisting risk.SNAX
Registration Filing29 Nov 2025 - Raising capital to fund operations and avoid Nasdaq delisting amid ongoing financial losses.SNAX
Registration Filing28 Nov 2025